BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Young BA, Blacksher E, Cavanaugh KL, Freedman BI, Fullerton SM, Kopp JB, Umeukeje EM, West KM, Wilson JG, Burke W; APOL1 Stakeholders Project. Apolipoprotein L1 Testing in African Americans: Involving the Community in Policy Discussions. Am J Nephrol 2019;50:303-11. [PMID: 31480040 DOI: 10.1159/000502675] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Griffith DM, Umeukeje EM. Navigating to Kidney Health Equity. J Am Soc Nephrol 2022;33:1242-4. [PMID: 35728885 DOI: 10.1681/ASN.2022040421] [Reference Citation Analysis]
2 Harris DD, Fleishman A, Pavlakis M, Pollak MR, Baliga PK, Rohan V, Kayler LK, Rodrigue JR. Apolipoprotein L1 Opinions of African American Living Kidney Donors, Kidney Transplant Patients, and Nonpatients. J Surg Res 2022;277:116-24. [PMID: 35489216 DOI: 10.1016/j.jss.2022.04.011] [Reference Citation Analysis]
3 Daneshpajouhnejad P, Kopp JB, Winkler CA, Rosenberg AZ. The evolving story of apolipoprotein L1 nephropathy: the end of the beginning. Nat Rev Nephrol 2022. [PMID: 35217848 DOI: 10.1038/s41581-022-00538-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 West KM, Cavanaugh KL, Blacksher E, Fullerton SM, Umeukeje EM, Young B, Burke W. Stakeholder Perspectives on Returning Nonactionable Apolipoprotein L1 (APOL1) Genetic Results to African American Research Participants. J Empir Res Hum Res Ethics 2022;17:4-14. [PMID: 34870514 DOI: 10.1177/15562646211063267] [Reference Citation Analysis]
5 IItis AS, Lewis A, Neely S, Seaton SW, Jeong SH. Applying Genetic and Genomic Tools to Psychiatric Disorders: A Scoping Review. HEC Forum 2021. [PMID: 34850314 DOI: 10.1007/s10730-021-09465-5] [Reference Citation Analysis]
6 Lopez-Soler RI, Garcia-Roca R, Lee DD. Disparities in living donation. Curr Opin Organ Transplant 2021;26:542-6. [PMID: 34375319 DOI: 10.1097/MOT.0000000000000912] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lentine KL, Mannon RB. Apolipoprotein L1: role in the evaluation of kidney transplant donors. Curr Opin Nephrol Hypertens 2020;29:645-55. [PMID: 33009133 DOI: 10.1097/MNH.0000000000000653] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 9.0] [Reference Citation Analysis]
8 Freedman BI, Poggio ED. APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (pro). Kidney Int 2021;100:27-30. [PMID: 34154719 DOI: 10.1016/j.kint.2020.11.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Cerdeña JP, Tsai J, Grubbs V. APOL1, Black Race, and Kidney Disease: Turning Attention to Structural Racism. American Journal of Kidney Diseases 2021;77:857-60. [DOI: 10.1053/j.ajkd.2020.11.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Freedman BI, Burke W, Divers J, Eberhard L, Gadegbeku CA, Gbadegesin R, Hall ME, Jones-Smith T, Knight R, Kopp JB, Kovesdy CP, Norris KC, Olabisi OA, Roberts GV, Sedor JR, Blacksher E. Diagnosis, Education, and Care of Patients with APOL1-Associated Nephropathy: A Delphi Consensus and Systematic Review. J Am Soc Nephrol 2021:ASN. [PMID: 33853887 DOI: 10.1681/ASN.2020101399] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Bruggeman LA, Sedor JR, O'Toole JF. Apolipoprotein L1 and mechanisms of kidney disease susceptibility. Curr Opin Nephrol Hypertens 2021;30:317-23. [PMID: 33767059 DOI: 10.1097/MNH.0000000000000704] [Reference Citation Analysis]
12 Mohottige D, Diamantidis CJ, Norris KC, Boulware LE. Racism and Kidney Health: Turning Equity Into a Reality. Am J Kidney Dis 2021;77:951-62. [PMID: 33639186 DOI: 10.1053/j.ajkd.2021.01.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Berrigan M, Austrie J, Fleishman A, Tercyak KP, Pollak MR, Pavlakis M, Rohan V, Baliga PK, Kayler LK, Feeley TH, Rodrigue JR. Opinions of African American adults about the use of apolipoprotein L1 (ApoL1) genetic testing in living kidney donation and transplantation. Am J Transplant 2021;21:1197-205. [PMID: 32659871 DOI: 10.1111/ajt.16206] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
14 West KM, Blacksher E, Cavanaugh KL, Fullerton SM, Umeukeje EM, Young BA, Burke W. At the Research-Clinical Interface: Returning Individual Genetic Results to Research Participants. Clin J Am Soc Nephrol 2020;15:1181-9. [PMID: 32041801 DOI: 10.2215/CJN.09670819] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]